Stay updated with breaking news from Bioaffinity Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating) dropped 0.4% during mid-day trading on Tuesday . The stock traded as low as $1.76 and last traded at $1.85. Approximately 8,357 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 765,556 shares. The stock had previously closed at […]
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today will present the poster... | May 22, 2023
BioAffinity Technologies (NASDAQ:BIAF – Get Rating) and Bioqual (OTCMKTS:BIOQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Earnings & Valuation This table compares bioAffinity Technologies and Bioqual’s […]
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for... | May 15, 2023
15.05.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three months ended March ...